KP Tissue Inc. (TSE:KPT - Free Report) - Equities research analysts at Desjardins issued their Q1 2025 earnings per share (EPS) estimates for KP Tissue in a note issued to investors on Thursday, March 6th. Desjardins analyst F. Tremblay anticipates that the company will earn $0.12 per share for the quarter. Desjardins currently has a "Hold" rating and a $8.50 price objective on the stock. The consensus estimate for KP Tissue's current full-year earnings is $0.44 per share. Desjardins also issued estimates for KP Tissue's Q2 2025 earnings at $0.07 EPS, Q3 2025 earnings at $0.10 EPS, Q4 2025 earnings at $0.12 EPS and FY2026 earnings at $0.56 EPS.
Separately, CIBC cut their price target on shares of KP Tissue from C$9.00 to C$8.50 in a report on Wednesday, January 15th.
Get Our Latest Analysis on KP Tissue
KP Tissue Price Performance
TSE KPT traded down C$0.07 on Monday, hitting C$7.86. 5,675 shares of the company were exchanged, compared to its average volume of 15,274. KP Tissue has a twelve month low of C$7.66 and a twelve month high of C$9.05. The firm has a market capitalization of C$78.55 million, a P/E ratio of 12.31, a price-to-earnings-growth ratio of -0.88 and a beta of 0.37. The company's 50 day moving average price is C$8.01 and its 200-day moving average price is C$8.21.
KP Tissue Company Profile
(
Get Free Report)
KP Tissue Inc, through its interest in Kruger Products L.P., produces, distributes, markets, and sells a range of disposable tissue products in Canada and the United States. The company operates through two segments, Consumer and Away-From-Home. It offers bathroom and facial tissues, paper towels, and napkins.
Featured Articles
Before you consider KP Tissue, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and KP Tissue wasn't on the list.
While KP Tissue currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
